Opendata, web and dolomites

Gasgon SIGNED

Development of a Novel Medical Device to Remove Air Bubbles from Medicines, Which Will Improve Patient Safety and Reduce Costs of IV Infusion

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Gasgon project word cloud

Explore the words cloud of the Gasgon project. It provides you a very rough idea of what is the project "Gasgon" about.

patients    flow    extreme    mechanical    patent    receiving    puts    reliably    removing    billion    financial    80    dysfunction    risk    first    intervene    fluid    complications    stroke    remove    gasgon    environment    regardless    infusion    medicine    intravenous    air    heart    line    automatic    carry    disposable    outcomes    global    interrupting    block    burden    intensive    adverse    sepsis    reduce    reducing    alarms    potentially    man    brain    infusions    deadly    prescribed    inpatients    invented    innovation    electronic    medications    place    performance    embolism    solutions    death    220mn    treatments    efficacy    acts    gas    providers    globally    vent    optimise    entering    majority    market    unsuitable    dose    attack    treatment    medical    filters    over    blocking    fluids    human    wasted    bubbles    complication    opportunity    labour    enter    blood    unmet    pending    hours    form    clinical    bubble    positively    patient    venous    position    break    strain    serious    clinicians    healthcare    health    disruptive   

Project "Gasgon" data sheet

The following table provides information about the project.

Coordinator
TESSEN SOLUTIONS LIMITED 

Organization address
address: RUBICON CENTRE, BISHOPSTOWN. CO. CORK, IRELAND
city: Cork
postcode: n.a.
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2020
 Duration (year-month-day) from 2020-01-01   to  2020-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TESSEN SOLUTIONS LIMITED IE (Cork) coordinator 50˙000.00

Map

 Project objective

Over 2 billion medical intravenous (IV) infusions occur each year globally, with over 80% of inpatients receiving IV treatment. Each of these infusions carry a serious health risk – the risk that gas bubbles enter with the fluid and block blood flow in patients. Air Embolism, a potentially deadly complication of IV infusion, is a result of bubbles entering the venous system and blocking blood flow leading to serious adverse complications for patients such as Sepsis, Stroke, Brain Dysfunction and Heart Attack. In extreme cases death can occur. Gasgon Medical has built a break-through and disruptive technology to reduce risk and optimise fluid management in common medical IV treatments. Currently clinicians must intervene to remove every bubble in every infusion, a labour-intensive practice that puts a strain on healthcare resources, with wasted man-hours and reduced efficacy of the medicine dose. Technology solutions on the market include electronic alarms and in-line filters – these are unsuitable in the majority of cases and place a significant human and financial burden on healthcare providers. Our innovation, which is a new form of ‘vent’ technology, will solve this unmet clinical need. Gasgon Medical has invented the first mechanical, in-line, automatic vent capable of removing bubbles from IV fluids regardless of position or environment. Our Patent-pending disposable vent acts quickly and reliably without interrupting or reducing the prescribed dose of medications. This represents a major technology advancement over current methods of managing risk in IV infusions. Gasgon Medical can lead a €220mn IV vent opportunity bringing an exciting European innovation to the global market. This novel Gasgon vent technology has the potential to positively impact healthcare delivery and performance, leading to better patient outcomes.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GASGON" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GASGON" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

IMPACT (2019)

Improving DNA Analysis for Correct Healthcare

Read More  

MIGRATECH 4.0 (2019)

The revolution in micro-granulation technology for eco-friendly, production efficient, superior ceramic tiles

Read More  

EVERCAM (2020)

Intelligent Vision System for Improved Communication and Higher Productivity in Construction

Read More